| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Assessing the value of cancer treatments from real world data—Issues, empirical examples and lessons learnt
|
Moen, F.
|
|
2017
|
11 |
C |
p. 32-37
6 p.
|
article
|
| 2 |
Assessment of value for resource allocation in cancer care
|
Lindgren, Peter
|
|
2017
|
11 |
C |
p. 12-18
7 p.
|
article
|
| 3 |
Costs matter: The impact of disclosing treatment costs and provider profit on patients’ decisions
|
Howe, Rebecca
|
|
2017
|
11 |
C |
p. 42-47
6 p.
|
article
|
| 4 |
Ethics, priorities and cancer
|
Culyer, Anthony J.
|
|
2017
|
11 |
C |
p. 6-11
6 p.
|
article
|
| 5 |
Evidence, value and hope — Allocating resources for cancer
|
|
|
2017
|
11 |
C |
p. 1-5
5 p.
|
article
|
| 6 |
Is willingness to pay higher for cancer prevention and treatment?
|
Shah, Koonal Kirit
|
|
2017
|
11 |
C |
p. 60-64
5 p.
|
article
|
| 7 |
QALYs as a measure of value in cancer
|
Devlin, Nancy J.
|
|
2017
|
11 |
C |
p. 19-25
7 p.
|
article
|
| 8 |
Rare cancers—Rarity as a cost and value argument
|
Graf von der Schulenburg, J.-Matthias
|
|
2017
|
11 |
C |
p. 54-59
6 p.
|
article
|
| 9 |
Value and cancer medicines—A personal view
|
Paterson, Kenneth R
|
|
2017
|
11 |
C |
p. 26-31
6 p.
|
article
|
| 10 |
Value assessment in precision cancer medicine
|
Towse, Adrian
|
|
2017
|
11 |
C |
p. 48-53
6 p.
|
article
|
| 11 |
Value-based payment for oncology services in the United States and France
|
Robinson, James C.
|
|
2017
|
11 |
C |
p. 38-41
4 p.
|
article
|
Journal description